Status:
UNKNOWN
Metal Stents (Moving Cell Stent) for Inoperable Tumors of the Bile Duct Tract
Lead Sponsor:
Johannes Vermehren
Collaborating Sponsors:
Klinikum Stadt Hanau
Conditions:
Bile Duct Stricture
Bile Duct Cancer
Eligibility:
All Genders
18-100 years
Brief Summary
In this feasibility study (non-randomized), the applicability of a new "moving cell" biliary stents (by HILZO) in Klatskin tumors (bile duct obstruction) will be investigated. The HILZO Moving-Cell S...
Detailed Description
ERCP (endoscopic retrograde cholangiopancreatography) is the standard method of treating diseases in the biliopancreatic system and the treatment goal is achieved in a very high proportion of the stud...
Eligibility Criteria
Inclusion
- • Indication for the palliative metal-stent system for malignant stenosis due to biliary cancer (Klatskin tumor).
Exclusion
- Age under 18 years
- Pregnancy
- Contraindication to an endoscopic examination
- Life expectancy under 3 months
Key Trial Info
Start Date :
December 31 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03788655
Start Date
December 31 2018
End Date
June 1 2021
Last Update
December 27 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinikum der J. W. Goethe-Universität
Frankfurt am Main, Germany, 60590